Company Search:
Advanced Search
Sponsored Links
Krka DD Novo Mesto Company Snapshot
Krka DD Novo Mesto operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Krka DD Novo Mesto with three other pharmaceutical manufacturers in Europe: Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag of Hungary (2016 sales of 389.69 billion Hungarian Forints [US$1.54 billion] of which 81% was Pharmaceutical Manufacturing and Sale), Orion Oyj of Finland (1.07 billion Euro [US$1.31 billion] of which 95% was Pharmaceuticals Business), and Recordati SpA which is based in Italy (1.15 billion Euro [US$1.41 billion] of which 84% was Pharmaceuticals).

Sales Analysis. Krka DD Novo Mesto reported sales of 1.17 billion Euro (US$1.44 billion) for the year ending December of 2016. This represents a very small increase of 0.8% versus 2015, when the company's sales were 1.16 billion Euro. Despite this increase, sales are still slightly below the level achieved in 2014, when Krka DD Novo Mesto reported sales of 1.19 billion Euro. The sales level in 2016 was fairly close to the level five years ago: in 2011, Krka DD Novo Mesto had sales of 1.08 billion Euro. Sales of Others saw an increase that was more than double the company's growth rate: sales were up 14.1% in 2016, from 39.87 million Euro to 45.50 million Euro. Krka DD Novo Mesto also saw significant increases in sales in Eastern Europe (up 1.5% to 332.29 million Euro) and South East Europe (up 4.5% to 58.26 million Euro) . Not all segments of Krka DD Novo Mesto experienced an increase in sales in 2016: sales of European Union fell 0.4% to 738.38 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Krka DD Novo Mesto
  Stock Performance Chart for Krka DD Novo Mesto
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 58.00
(Figures in Euro)
1 Week -0.3%   13 Weeks 3.9%  
4 Weeks 2.7%   52 Weeks 11.5%  
Krka DD Novo Mesto Key Data:
  Ticker: KRKG Country: Slovenia
  Exchanges: LJB Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,174,424,000
(Year Ending Jan 2017).
Employees: 10,889
  Currency: Euro Market Cap: 1,865,104,666
  Fiscal Yr Ends: December Shares Outstanding: 32,156,977
  Share Type: Ordinary Closely Held Shares: 6,479,863
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.